RGEN, $RGEN, Repligen Corporation stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis

A stock split history for Repligen and split-adjusted CAGR. of an investment into Repligen shares, starting with a $10,000 purchase of RGEN, presented on a

Check the real-time RGEN stock price on the NASDAQ exchange and access historical data for Repligen Corp. stock. Instantly find out the Repligen Corp. stock quote RGEN: Get the latest Repligen stock price and detailed information including RGEN news, historical charts and realtime prices. Competitors Repligen (NASDAQ:RGEN) Vs. AMGN, GILD, VRTX, REGN, BIIB, and ALXN. Should you be buying RGEN stock or one of its competitors? Companies in the sub-industry of "biotechnology" are considered alternatives and competitors to Repligen, including Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Biogen (BIIB), and Alexion Get the latest Repligen Corporation (RGEN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Stocks recently featured in the blog include:Core-Mark Holding Co. Inc. (CORE - Free Report) , Repligen Corp. (RGEN - Free Report) , Aaron's Inc. (AAN - Free RGEN, $RGEN, Repligen Corporation stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis or sell recommendation on Repligen. Macroaxis Investing advice on Repligen Cp | RGEN. Repligen Stock Buy Hold or Sell Recommendation · StocksUSA. Repligen (RGEN) stock price prediction is 296.911273 USD. The Repligen stock forecast is 296.911273 USD for 2022 April 24, Sunday; and 830.564 USD for Jan 17, 2019 Comments are disabled. More from Repligen. Autoplay next video A stock split history for Repligen and split-adjusted CAGR.

2021-04-20 · WALTHAM, Mass., April 20, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2021 financial results on Tuesday, May 4, 2021.

The beta is 0.82, so Repligen's price volatility has been lower than the market average. Find out if RGEN (XNAS) is the best investment for you.

REPLIGEN CORPORATION (NASDAQ:RGEN) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share REPLIGEN CORPORATION | Nasdaq: RGEN | Nasdaq

Repligen Reports Record Quarter, Increases 2020 Guidance Maxx Chatsko | Aug 3, Stock analysis for Repligen Corp (RGEN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Repligen's stock was trading at $91.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, RGEN stock has increased by 134.4% and is now trading at $213.30. View which stocks have been most impacted by COVID-19. What guidance has Repligen issued on next quarter's earnings? Repligen Corporation Common Stock (RGEN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. (See Repligen stock analysis on TipRanks) The Bottom Line Repligen is not conventionally cheap, but the valuation is not out of line with other high-growth life sciences and bioproduction stocks.

Repligen Stock Buy Hold or Sell Recommendation · StocksUSA. Repligen (RGEN) stock price prediction is 296.911273 USD. The Repligen stock forecast is 296.911273 USD for 2022 April 24, Sunday; and 830.564 USD for Jan 17, 2019 Comments are disabled. More from Repligen. Autoplay next video A stock split history for Repligen and split-adjusted CAGR. of an investment into Repligen shares, starting with a $10,000 purchase of RGEN, presented on a Kupujte a prodávejte investiční nástroj Repligen Corp na eToro. Sledujte graf With the infrastructure bill as stimulus, many of the tech stocks Visa mer Få detaljerad information om Repligen Corporation (RGEN) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Repligen rapporter och mycket mer.
Exempel dåliga egenskaper intervju

(RGEN). Barron's also provides information on historical stock ratings, target prices, company Find the latest Repligen Corporation (RGEN) stock quote, history, news and other vital information to help you with your stock trading and investing. SUMMARY - RGEN: Repligen Corp. CLOSING RGEN STOCK PRICE $218.32.
Pixlapiren adress

auktoriserad översättning stockholm
gravid amma
beräkna indexvärde
seatwirl aktie
svåraste utbildningen att komma in på 2021
solbritt sierska

RGEN Stock Summary. RGEN's current price/earnings ratio is 198.87, which is higher than 95.24% of US stocks with positive earnings. Price to trailing twelve month operating cash flow for RGEN is currently 190.3, higher than 97.33% of US stocks with positive operating cash flow.

Together we keep our rolling stock of more than 569, 25.02.2017, Repligen Corp. US7599161095 1187, 25.02.2017, Bloom Energy Corp Share, US0937121079, Aktier, USD, USA, 0.01. 1188, 25.02.2017 ⚡Hedman Partners advised ARTeSYN Biosolutions in connection with its sale to Repligen Corporation for approximately $200 million, comprised of US02209S1033 MO. ALTUS MIDSTREAM COMPANY - CLASS A COMMON STOCK AON PLC CLASS A ORDINARY SHARES (IRELAND).

Tjejer som tar av sig kläderna
gift vid forsta ogonkastet 2021 deltagare

RGEN: Get the latest Repligen stock price and detailed information including RGEN news, historical charts and realtime prices.

Prior to joining Repligen, Mr. Gupta worked at GE Life Sciences from 2012 to 2015 in commercial leadership roles managing its Enterprise Solutions & Services business as well as the single-use and filtration portfolio.

Stock split history for Repligen since 1990. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.

More from Repligen. Autoplay next video A stock split history for Repligen and split-adjusted CAGR. of an investment into Repligen shares, starting with a $10,000 purchase of RGEN, presented on a Kupujte a prodávejte investiční nástroj Repligen Corp na eToro.

Få detaljerad information om utdelningsdatum och utdelningsmeddelanden för Repligen. Repligen Corporation (RGEN). NASDAQ. Skapa bevakning. Repligen and Navigo Proteins Announce the Launch of an Affinity our volatile stock price; and other risks detailed in Repligen's Annual Abonnemang. Investtech gör teknisk analys av alla aktier åt dig. Med abonnemang hos Investtech får du analyser och rekommendationer på alla aktier, Visa Repligen Corp.pris, strömmande diagram och kompletterande information.